USPTO serial 79229551
RHEACELL
Reviewed by CopyMark Law Group
Reg. 5694020Status 739Registered
- Filing date
- Status date
- Registration date
- Mar 12, 2019
- Examiner
- VAGHANI, MAYUR C
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with RHEACELL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
69120 Heidelberg, DE
69120 Heidelberg, DE
Heidelberg, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Claudia W. Stangle
Claudia W. Stangle Leydig, Voit & Mayer, Ltd.Two Prudential Plaza, 180 N. Stetson AveSuite 4900Chicago, IL 60601Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical [ and veterinary ] preparations for treatment of skin diseases; pharmaceutical [ and veterinary ] preparations for the treatment of vertigo; pharmaceutical [ and veterinary ] preparations for treatment of nausea; [ pharmaceutical and veterinary preparations for treatment of vomiting; pharmaceutical and veterinary preparations for treatment of migraine; ] pharmaceutical [ and veterinary ] preparations for treatment of disease and disorders of the respiratory system, the gastrointestinal system, the endocrine system, the cardiovascular system, the nervous system, the musculoskeletal system, [ the urinary system, ] the integumentary system [, and the reproductive system ]; pharmaceutical [ and veterinary ] preparations for treatment of blood diseases and disorders; pharmaceutical [ and veterinary ] preparations, namely, antibiotics, immune suppressants, anti-inflammatory pharmaceuticals; pharmaceutical [ and veterinary ] preparations for wound healing; pharmaceutical [and veterinary preparations for anti-aging, namely, stem cells for medical and aesthetic purposes, [ fibroblasts for medical and aesthetic purposes, ] surgical tissue implants obtained from stem cells [ , surgical tissue implants obtained from fibroblasts ] | ACTIVE | — |
| 042 | Scientific and technological services, namely medical and scientific research services in the fields of regenerative medicine and tissue engineering, scientific research, testing and analysis services in the field of regenerative medicine and tissue engineering, consulting services relating to scientific research in the fields of regenerative medicine and tissue engineering, providing information on medical and scientific research on pharmaceutical products, providing information in the form of expert reports relating to scientific research in the fields of regenerative medicine and tissue engineering; Industrial analysis, namely chemical analysis; research services, namely laboratory research services relating to pharmaceuticals, medical, biomedical and stem cell research in the field of regenerative medicine and tissue engineering, scientific and medical research and development for medical purposes in the field of regenerative medicine and tissue engineering, research and development services relating to new products for others, research in the field of biotechnology, research in the field of gene therapy, research and development in the field of immunology, research and development in the field of antibodies, research and development in the field of antibody technology, research and development in the field of bacteriology, research and development in the field of gene expression systems, research and development in the field of vaccines, pharmaceutical research and development services, research and development services in the field of biotechnology | ACTIVE | — |
| 044 | Medical services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by RHEACELL GmbH & Co. KG
- Other trademarks owned by RHEACELL GmbH & Co. KG
- Other trademarks owned by RHEACELL GmbH & Co. KG
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named RHEACELL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 14, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 7, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 7, 2025 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Jul 7, 2025 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Jun 30, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 27, 2025 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Mar 12, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 4, 2024 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jul 19, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 1, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 1, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 12, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 12, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 25, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 25, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 5, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 13, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 24, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 23, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 23, 2018 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 19, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 19, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 10, 2018 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 10, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 21, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 21, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 21, 2018 | ALIE | ASSIGNED TO LIE | — |
| Aug 1, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 8, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 23, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 23, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 19, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 18, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 17, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 4, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 31, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 29, 2018 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |